Discover the complete list of Active Pharmaceutical Ingredients (APIs) manufactured or distributed by MannKind Corp. View detailed product information, certifications, and sourcing options for each API. Connect with MannKind Corp for compliant, high-quality pharmaceutical ingredients trusted by global clients.
Country: U.S.A.
Supplier Description: MannKind Corporation is a biopharmaceutical company specializing in the discovery, development, and commercialization of therapeutic products, primarily focusing on diseases such as diabetes and pulmonary arterial hypertension. The company is known for its lead product, Afrezza, a rapid-acting inhaled insulin used in diabetes management. Founded in 1991 by Alfred E. Mann, it is headquartered in Danbury, Connecticut, with operations also in Westlake Village, California. MannKind concentrates on innovative delivery technologies, including dry-powder inhalation devices designed to deliver medicines directly to the lungs for effective treatment. The company has been involved in developing treatments for endocrine and orphan lung diseases and has a pipeline including clinical trials for conditions such as nontuberculous mycobacterial (NTM) lung disease. - Show More
